Search results
Found 7356 matches for
The New Yorker features Nuffield Department of Clinical Neuroscience's Head of Department Professor Irene Tracey, and her research into the neuroscience of pain.
Four Oxford researchers elected to the US National Academy of Science
6 May 2025
Last week, the National Academy of Sciences in the US announced the election of 120 members and 30 international members in recognition of their distinguished and continuing achievements in original research. Election to membership in the NAS is a mark of excellence in science and considered one of the highest honours that a scientist can receive.
T-cell Receptors (TCR) drive Chimeric Antigen Receptors (CAR)
1 May 2025
Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer treatments. This study, published in Cell, demonstrates that engineering T-cells to express both a Chimeric Antigen Receptor (CAR) and a T-cell Receptor (TCR) can improve their ability to distinguish between cancerous and healthy tissues—addressing a major challenge in current immunotherapy.
Latin-American genetic data available securely to approved researchers worldwide
1 May 2025
Genetic data from the largest blood-based prospective study of a Latin-American population are now available securely to academic researchers worldwide through the DNAnexus Trusted Research Environment (TRE).
Lowering levels of Lipoprotein(a) could reduce the risk of heart attack and some types of stroke
1 May 2025
Researchers at Oxford Population Health studying genetic variants that control levels of Lipoprotein(a), or Lp(a) discovered that lowering Lp(a) could reduce the risk of heart attack and large artery stroke in both East Asians and Europeans. The study is published in Circulation.
RDM researchers edit new edition of seminal haematology textbook
1 May 2025
Professor Adam Mead is Editor-in-Chief and Graham Collins and Deborah Hay two of the editors for the eighth edition of this key reference work, now in its sixth decade.
New guidelines published for monitoring IBD patients to prevent bowel cancer
1 May 2025
Researchers and clinicians have developed major new guidelines for the monitoring of patients with inflammatory bowel disease (IBD) to prevent them going on to develop bowel cancer.
A landmark experiment published in Nature puts leading theories of consciousness to the test
30 April 2025
Professor Ole Jensen is part of a global consortium that embraced a novel collaborative approach to investigating one of the brain’s greatest mysteries
Oxford-led cross-divisional collaboration wins the prestigious Cozzarelli Prize
30 April 2025
A collaborative study between the Medical Sciences Division and the Mathematical, Physical and Life Sciences Division at the University of Oxford has been awarded the 2024 PNAS Cozzarelli Prize in Biomedical Science.
New study confirms malaria drug safe for children and reduces disease burden
30 April 2025
A major study in The Lancet Infectious Diseases confirms that single low-dose primaquine is safe and effective in reducing malaria transmission in young children. Analysing data from over 6,000 patients, researchers found it effective even in young children and areas with high malaria burden.
New study launched investigating the day-to-day experience of patients with psychiatric disorders
29 April 2025
The collaboration between the University of Oxford's Department of Psychiatry, Boehringer Ingelheim and Cumulus Neuroscience is the first of its kind.
New research reveals shared genetic link between endometriosis and immune conditions
29 April 2025
Research published in the journal Human Reproduction reveals that women with endometriosis are at a significantly higher risk for developing a range of autoimmune, autoinflammatory, and mixed-pattern diseases.
Celebrating 10 years of International Health and Tropical Medicine (IHTM)
28 April 2025
On the 25 and 26 April the MSc in International Health and Tropical Medicine, IHTM, celebrated its tenth anniversary as an internationally renowned programme for future global health leaders, with over 100 alumni travelling from around the world to join colleagues, current students and guests in Oxford.
Study shows urgent change needed to reduce deaths from malaria and meningitis in comatose African children
25 April 2025
Results of two parallel studies show that one in four African children hospitalised with malaria and coma have an additional infection, and that giving antibiotics with antimalarials could help reduce death rates of comatose children.
Study finds that Treg depletion suppresses tumour growth
24 April 2025
A new study, co-lead by Dr Felipe Galvez-Cancino from the Centre for Immuno-Oncology, has shown that Treg cell depletion can suppress tumour growth in one of the deadliest types of cancer.
Collaborative research project awarded Pancreatic Cancer UK grant
24 April 2025
Academic Clinical Lecturer Mr Keaton Jones has been awarded a grant from Pancreatic Cancer UK to carry out pioneering pancreatic cancer research within the Nuffield Department of Surgical Sciences.
Climate and the Environment - Impact on Global and Mental Health
23 April 2025
The climate crisis is a health emergency which is threatening the lives and wellbeing of communities around the world in many ways – including through air pollution, rising temperatures, the spread of infectious diseases and antimicrobial resistance.
Cancer Research UK (CRUK) funding for research into earlier detection of relapse in people with multiple myeloma
23 April 2025
Dr Karthik Ramasamy and team will assess a new mass spectrometry-based monitoring technique for its ability to predict and identify early disease relapse.
Sarah Gilbert receives Royal Society of Chemistry Honorary Fellowship
23 April 2025
PSI Principal Investigator Professor Dame Sarah Gilbert has been made an Honorary Fellow of the Royal Society of Chemistry.
New Study Finds Common Virus May Improve Skin Cancer Treatment Outcomes
23 April 2025
A new study led by the University of Oxford has revealed that a common and usually harmless virus may positively influence how skin cancer patients respond to current treatments.